Risk Factors Update Summary
- Departure of executive officers resulted in accelerated recognition of unamortized compensation expense of approximately $15.6 million and $4.6 million.
- Issued $1.0 billion unsecured senior notes at 3.95% with a weighted-average maturity of 21 years.
- Accumulated depreciation rose from $3.8 billion in 2022 to $4.9 billion in 2023.
- Projected capital contributions from partners in consolidated real estate joint ventures to fund construction through 2027 increased significantly from $1,246,000 to $1,449,518.
- Real estate and non-real estate assets were added to the risk factors disclosure.
- Sales of real estate assets and impairment charges changed significantly, with a decrease in sales from $615 million to $461 million and an increase in impairment charges from $65 million to $461 million.
- Established Labspace ® asset base predominantly concentrated in markets with high barriers to entry.
- The Inflation Reduction Act of 2022 allows direct negotiation of Medicare drug prices, impacting select drugs covered by Medicare Part B and Part D.
- Added new development projects aggregating 467,567 RSF, generating $57 million incremental annual net operating income.
- Leasing activity increased significantly with 336 leases executed, a weighted-average lease term increase from 8 to 11 years.
- Enhanced cybersecurity risk management processes implemented, including incident detection, response, and vulnerability management.
- Stockholders' equity increased significantly from $20,812 to $15,896 million.
- Long-Term Incentive Grants amended to increase target LTI grant value to $3,600,000.
- 90% of top 20 tenants set net-zero carbon goals by Dec 31, 2023, up from unspecified.
- The property at 651 Gateway Boulevard is projected to have a 47.1% occupancy rate.
- Repaid $500.0 million of 5.15% unsecured senior notes due 2053 with an effective interest rate.
- Sales of 10935, 10945, and 10955 Alexandria Way are expected to generate $177,828,000.
- Total equity decreased from $972,387 to $606,513 million, a significant change.
- Focus on creating new and enhancing existing mega campuses to defend against competitive supply.
- The Inflation Reduction Act of 2022 led to over $278 billion in new green investments and jobs in the U.S.
- The number of properties classified as held for sale decreased from 10 to seven.
- Updated guidance for EPS attributable to Alexandria's common stockholders - diluted for the year ending December 31, 2023, increased from $3.41 to $3.49.
- The estimated annual amortization of in-place leases decreased from $133,000 to $107,000, indicating a reduction in amortization expenses.
- Increased rental rates by 29.4%, 31.0%, and 37.9% for the years ended December 31, 2023, 2022, and 2021, respectively.
- Increase in the number of properties held for sale from 297 to 1,284, representing a significant change.
- Long-Term Incentive Grants now include a Trading Restriction on vested shares for one year.
- The consumer price index rose by approximately 6% in the past twelve months.
- COP28 reaffirmed limiting global temp rise to 1.5°C, impacting climate change policies.
- Investment loss increased by $195.4 million to $195.4 million for the year ended December 31, 2023.
- Rental rate growth improved from 31% to 29% and 22% to 15% (cash basis) on renewed and re-leased space.
- Forecasting challenges prevent providing reconciliation for fixed-charge coverage ratio due to market-dependent items.
- Net debt and preferred stock rose from $8.4 billion in 2022 to $10.7 billion in 2023.
- Depreciation and amortization of real estate assets increased from $5.50 to $5.69.
- Acquisitions in 2023 totaled $433,419, with completed acquisitions including $202,997 and pending acquisitions of $250,000 to $750,000.
- Impairment charges increased notably, with new impairment charges totaling $461 million compared to $65 million previously.
- Revenues increased from $2,576,040 to $2,842,456, a notable rise of $266 million.
- Anticipated growth in funds from operations per share from $8.97 in 2023 to $9.47 in 2024.
- Gross assets increased from $30.2 billion in 2022 to $35.5 billion in 2023.
- Reduction in ground lease rental expense as a percentage of net operating income from 7% to 5%.
- Legislation in California and cities like New York and San Francisco mandates net-zero GHG emissions by 2045.
- Unsecured senior notes payable increased from $8.3 billion in 2022 to $11.1 billion in 2023.
- The development project at 401 Park Drive is anticipated to total 133,578 RSF.
- Capital plan included $1.4 billion funding from dispositions and partial interest sales, with $439.0 million completed in Q4 2023.
- Legislation in California requires GHG disclosures, affecting climate risk management.
- The federal funds rate was raised from nearly zero to a range between 0.25% and 0.50%.
- The total cost of real estate assets increased from $34 billion to $36 billion.
- Expect real estate dispositions and sales of partial interests ranging from $900 million to $2.4 billion.
- Unrealized losses on investments increased by $18 million to $77 million for the year ended December 31, 2023.
- Deposits increased by $5 million to $25 million as of December 31, 2023.
- Title Change for Peter M. Moglia to Chief Executive Officer and Chief Investment Officer.
- The California Privacy Rights Act expanded privacy rights, affecting personal data handling and compliance costs.
- Total equity capitalization increased from $1.3 billion in 2022 to $2 billion in 2023.
- The weighted-average remaining lease term decreased from approximately 8.0 years to 7.9 years, impacting lease obligations.
- Climate resilience roadmap developed to assess physical risks associated with climate change.
- Other income increased from $7,429 to $43,243, a substantial increase of $35,814.
- Net investment in direct financing lease decreased by $1.3 million to $40 million as of December 31, 2023.
- Allocation of unvested restricted stock awards increased from $0.05 to $0.07.
- The annual rent escalations approximating 3% were fixed or indexed based on the CPI.
- Deferred compensation plan increased by $6.8 million to $40.4 million for the year ended December 31, 2023.
- Solid same property net operating income growth of 3.4% in 2023 and anticipated growth of 1.5% in 2024.
- Total assets surged from $30.2 billion in 2022 to $35.5 billion in 2023.
- Expect to incur $2.2 billion to $3.3 billion in construction spending in 2024, funded partially through bond issuances.
- Expect to receive $1.2 billion in capital contributions from existing consolidated real estate joint venture partners.
- Accumulated depreciation increased from $4.35 billion to $4.98 billion.
- Dispositions included the sale of 100 Binney Street in Cambridge for $228,000, with a gain of $1,186 per RSF.
- Additions to real estate increased from $1.5 billion to $3.1 billion.
- Placed into service development and redevelopment projects aggregating 1.2 million RSF, generating $145 million incremental annual net operating income.
- GHG emissions mitigation strategy aligns with sustainability goals of innovative tenants.
- Total expenses increased from $1,642,024 to $2,687,325, a significant rise of $1,045,301.
- Operating lease right-of-use assets decreased by $42 million to $516 million as of December 31, 2023.
- Total future lease payments under operating leases decreased from $904 million to $848 million, reflecting changes in lease obligations.
- Future development projects increased to 5,592,452 square feet, with a total of 74,566,128 square feet upon completion.
- Funds from operations per share increased from $8 to $9.
- Potential future federal government shutdowns due to disagreements over the debt ceiling could disrupt operations.
- Completed acquisitions in 2024 with strong occupancy of 94.6% in 2023 and anticipated range of 94.6% to 95.6% in 2024.
- Completed acquisitions of five properties for $2.8 billion, accounted for as asset acquisitions.
- Deferred financing costs decreased by $0.9 million to $30.9 million for the year ended December 31, 2023.
- The loss of services of executive and senior officers could adversely affect the company.
- Investment loss in 2023 increased to $195.4 million from $52.3 million in 2022.
- Net income attributable to stockholders increased from $513,268 to $103,639 million.
- Rental rate increases of 29.4% in 2023 and anticipated increases of 15.0% in 2024.
- Short sellers' manipulative activities may lead to increased stock price volatility and regulatory inquiries.
- Expect to settle remaining outstanding forward equity sales agreements for approximately $102.4 million in 2023.
- Depreciation expense on properties increased from $530 million to $893 million.
- Investments in limited partnerships increased from $65 million to $75.5 million, indicating a higher investment commitment.
- Total square footage for acquisitions in 2023 was 433,419, with a total of 1,633,485 in value and $258,976 in gain.
- Net operating income increased from 4% to 5%.
- The company may experience substantial unanticipated delays that could impact revenue.
- Expect capitalized interest to range from $325 million to $355 million in 2024, reflecting a focus on completing highly leased projects.
- Disruptions at the FDA and other agencies may affect the ability of the healthcare industry.
- Sale of properties decreased from $56.7 million to $19.1 million.
- Lease expirations in 2023 included 3,876,007 RSF, with a percentage of expiring leases at 9.9% and $52.08 per RSF.
- Strategic investments in life science, agtech, and technology industries subject to market risks and sector-specific challenges.
- Leasing activity in 2023 normalized to historical average of 4.2 million RSF executed annually from 2013 to 2020.
- Established a new ATM program during Q1 2023 to issue common stock, preferred stock, debt, and other securities.
- Concentration of credit risk related to cash deposits exceeding FDIC insurance coverage may impact short-term liquidity.
- Straight-line rent revenue increased from $145 to $184.
- Total construction spending for 2024 projected at $2.975 billion, up from $2.672 billion.
- Deferred leasing costs decreased from $1,035,339 million to $996,116 million, showing a reduction in leasing-related expenses.
- Net income per share decreased from $3.18 to $0.54, a notable decrease.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1035443&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.